A phase I study of the CDK4/6 inhibitor, palbociclib in combination with cetuximab and intensity modulated radiation therapy (IMRT) for locally advanced squamous cell carcinoma of the head and neck (SCCHN); A result of dose escalation cohort

A phase I/II dose escalation study of the CDK4/6 inhibitor, palbociclib in combination with cetuximab and intensity modulated radiation therapy (IMRT) for locally advanced squamous cell carcinoma of the head and neck (SCCHN)

Annals of Oncology ◽

10.1093/annonc/mdy287.075 ◽

2018 ◽

Vol 29 ◽

pp. viii397

Author(s):

N. Ngamphaiboon ◽

S. Lukerak ◽

C. Jiarpinitnun ◽

A. Jinawath ◽

N. Jinawath ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Radiation Therapy ◽

Phase I ◽

Cell Carcinoma ◽

Dose Escalation ◽

Locally Advanced ◽

Dose Escalation Study ◽

Phase I dose-escalation study of NBTXR3 activated by intensity-modulated radiation therapy in elderly patients with locally advanced squamous cell carcinoma of the oral cavity or oropharynx

European Journal of Cancer ◽

10.1016/j.ejca.2021.01.007 ◽

2021 ◽

Vol 146 ◽

pp. 135-144

Author(s):

Caroline Hoffmann ◽

Valentin Calugaru ◽

Edith Borcoman ◽

Victor Moreno ◽

Emiliano Calvo ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Radiation Therapy ◽

Oral Cavity ◽

Elderly Patients ◽

Phase I ◽

Locally Advanced ◽

Dose Escalation Study ◽

Concurrent chemotherapy with intensity-modulated radiation therapy for locally advanced squamous cell carcinoma of the larynx and oropharynx: A retrospective single-institution analysis

Head & Neck ◽

10.1002/hed.21120 ◽

2009 ◽

Vol 31 (11) ◽

pp. 1447-1455 ◽

Cited By ~ 12

Author(s):

Nabil F. Saba ◽

Scott Edelman ◽

Mourad Tighiouart ◽

Jennifer Gaultney ◽

Lawrence W. Davis ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Radiation Therapy ◽

Cell Carcinoma ◽

Locally Advanced ◽

Concurrent Chemotherapy ◽

Single Institution ◽

Intensity Modulated ◽

Carcinoma Of The Larynx

Phase I study of weekly nab-paclitaxel + weekly cetuximab + intensity-modulated radiation therapy (IMRT) in patients with stage III–IVB head and neck squamous cell carcinoma (HNSCC)

Annals of Oncology ◽

10.1093/annonc/mdt579 ◽

2014 ◽

Vol 25 (3) ◽

pp. 689-694 ◽

Cited By ~ 15

Author(s):

M.G. Fury ◽

E.J. Sherman ◽

S.S. Rao ◽

S. Wolden ◽

S. Smith-Marrone ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Radiation Therapy ◽

Phase I ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Phase I Study ◽

Neck Squamous Cell Carcinoma ◽

Faculty Opinions recommendation of Phase I dose-escalation study of NBTXR3 activated by intensity-modulated radiation therapy in elderly patients with locally advanced squamous cell carcinoma of the oral cavity or oropharynx.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.739585406.793584072 ◽

2021 ◽

Author(s):

Lorenzo Livi ◽

Isacco Desideri

Keyword(s):

Squamous Cell Carcinoma ◽

Radiation Therapy ◽

Oral Cavity ◽

Elderly Patients ◽

Phase I ◽

Locally Advanced ◽

Dose Escalation Study ◽

Concurrent Weekly Cisplatin and Simultaneous Integrated Boost Intensity Modulated Radiation Therapy (SIB IMRT) of Locally Advanced Squamous Cell Carcinoma of the Head and Neck (LA SCCHN)

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2016.06.1601 ◽

2016 ◽

Vol 96 (2) ◽

pp. E386

Author(s):

P. Dubinsky ◽

G. Barilikova ◽

B. Jeremic ◽

P. Matula ◽

D. Nadzonova ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Radiation Therapy ◽

Cell Carcinoma ◽

Head And Neck ◽

Locally Advanced ◽

Intensity Modulated ◽

Integrated Boost ◽

Weekly Cisplatin

Early disease progression in a phase I study of bortezomib (B), cetuximab (C), and intensity-modulated radiation therapy (IMRT) for squamous cell carcinoma of the head and neck (SCCHN).

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.2575 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 2575-2575

Author(s):

C. Van Waes ◽

A. G. Duffy ◽

N. L. Simone ◽

M. K. Gibson ◽

Y. Arai ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Radiation Therapy ◽

Phase I ◽

Cell Carcinoma ◽

Head And Neck ◽

Disease Progression ◽

Phase I Study ◽

Early Disease ◽

Nivolumab and Ipilimumab Combined with Definitive Radiation Therapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck: In-field Toxicity Analysis of a Phase I Clinical Trial

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2020.07.2289 ◽

2020 ◽

Vol 108 (3) ◽

pp. S106-S107

Author(s):

G. Manukian ◽

J. Johnson ◽

A. Luginbuhl ◽

J.M. Curry ◽

D. Cognetti ◽

...

Keyword(s):

Clinical Trial ◽

Squamous Cell Carcinoma ◽

Radiation Therapy ◽

Phase I ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Locally Advanced ◽

Toxicity Analysis

Late toxicities in locally advanced head and neck squamous cell carcinoma treated with intensity modulated radiation therapy

Radiation Oncology Journal ◽

10.3857/roj.2020.00913 ◽

2021 ◽

Author(s):

Sandeep Muzumder ◽

Nirmala Srikantia ◽

Avinash H. Udayashankar ◽

Prashanth Bhat Kainthaje ◽

M. G. John Sebastian ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Radiation Therapy ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Locally Advanced ◽

Neck Squamous Cell Carcinoma ◽

Advanced Head ◽

Phase I study of concurrent chemoradiotherapy (CRT) with S-1 and cisplatin (CDDP) in patients (pts) with unresectable locally advanced squamous cell carcinoma of head and neck (SCCHN)

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.5575 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 5575-5575 ◽

Cited By ~ 2

Author(s):

M. Tahara ◽

H. Minami ◽

H. Mukai ◽

K. Kawada ◽

M. Kawashima ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Phase I ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Phase I Study ◽

Concurrent Chemoradiotherapy ◽

Locally Advanced ◽

Advanced Squamous Cell Carcinoma